|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4439 | |
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61K 9/50 |
| (11) | Number of the document | 2603206 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11746215.0 |
| Date of filing the European patent application | 2011-08-08 | |
| (97) | Date of publication of the European application | 2013-06-19 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/063602 |
| Date | 2011-08-08 |
| (87) | Number | WO 2012/019989 |
| Date | 2012-02-16 |
| (30) | Number | Date | Country code |
| 372693 P | 2010-08-11 | US |
| (72) |
CHATTERJI, Ashish, US
HUANG, Jingjun, US
KOENNINGS, Stephanie, CH
LINDENSTRUTH, Kai, DE
SANDHU, Harpreet K., US
SHAH, Navnit Hargovindas, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS |
| PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS |